124 related articles for article (PubMed ID: 19879421)
1. The role of clusterin (CLU) in malignant transformation and drug resistance in breast carcinomas.
Redondo M; Tellez T; Roldan MJ
Adv Cancer Res; 2009; 105():21-43. PubMed ID: 19879421
[TBL] [Abstract][Full Text] [Related]
2. Clusterin: a potential target for improving response to antiestrogens.
Toffanin S; Daidone MG; Miodini P; De Cecco L; Gandellini P; Cappelletti V
Int J Oncol; 2008 Oct; 33(4):791-8. PubMed ID: 18813793
[TBL] [Abstract][Full Text] [Related]
3. CLU "in and out": looking for a link.
Pucci S; Mazzarelli P; Nucci C; Ricci F; Spagnoli LG
Adv Cancer Res; 2009; 105():93-113. PubMed ID: 19879425
[TBL] [Abstract][Full Text] [Related]
4. Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.
Trougakos IP; Gonos ES
Adv Cancer Res; 2009; 104():171-210. PubMed ID: 19878777
[TBL] [Abstract][Full Text] [Related]
5. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer.
Cappelletti V; Gariboldi M; De Cecco L; Toffanin S; Reid JF; Lusa L; Bajetta E; Celio L; Greco M; Fabbri A; Pierotti MA; Daidone MG
Endocr Relat Cancer; 2008 Jun; 15(2):439-49. PubMed ID: 18508997
[TBL] [Abstract][Full Text] [Related]
6. Chapter 4: Regulation of Clusterin activity by calcium.
Pajak B; Orzechowski A
Adv Cancer Res; 2009; 104():33-58. PubMed ID: 19878772
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of clusterin immunoreactivity in breast cancer.
Krüger S; Ola V; Fischer D; Feller AC; Friedrich M
Neoplasma; 2007; 54(1):46-50. PubMed ID: 17203891
[TBL] [Abstract][Full Text] [Related]
8. Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control.
Shannan B; Seifert M; Boothman DA; Tilgen W; Reichrath J
J Mol Histol; 2006 Sep; 37(5-7):183-8. PubMed ID: 17048076
[TBL] [Abstract][Full Text] [Related]
9. Modulation of different clusterin isoforms in human colon tumorigenesis.
Pucci S; Bonanno E; Pichiorri F; Angeloni C; Spagnoli LG
Oncogene; 2004 Mar; 23(13):2298-304. PubMed ID: 14755245
[TBL] [Abstract][Full Text] [Related]
10. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer.
Shannan B; Seifert M; Leskov K; Willis J; Boothman D; Tilgen W; Reichrath J
Cell Death Differ; 2006 Jan; 13(1):12-9. PubMed ID: 16179938
[TBL] [Abstract][Full Text] [Related]
11. Clusterin and chemoresistance.
Djeu JY; Wei S
Adv Cancer Res; 2009; 105():77-92. PubMed ID: 19879424
[TBL] [Abstract][Full Text] [Related]
12. Nuclear clusterin accumulation during heat shock response: implications for cell survival and thermo-tolerance induction in immortalized and prostate cancer cells.
Caccamo AE; Desenzani S; Belloni L; Borghetti AF; Bettuzzi S
J Cell Physiol; 2006 Apr; 207(1):208-19. PubMed ID: 16331665
[TBL] [Abstract][Full Text] [Related]
13. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.
Trougakos IP; Gonos ES
Free Radic Res; 2006 Dec; 40(12):1324-34. PubMed ID: 17090421
[TBL] [Abstract][Full Text] [Related]
14. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis.
Moretti RM; Montagnani Marelli M; Mai S; Cariboni A; Scaltriti M; Bettuzzi S; Limonta P
Cancer Res; 2007 Nov; 67(21):10325-33. PubMed ID: 17974975
[TBL] [Abstract][Full Text] [Related]
15. The clusterin paradigm in prostate and breast carcinogenesis.
Rizzi F; Bettuzzi S
Endocr Relat Cancer; 2010 Mar; 17(1):R1-17. PubMed ID: 19903745
[TBL] [Abstract][Full Text] [Related]
16. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
17. Clusterin inhibits apoptosis by interacting with activated Bax.
Zhang H; Kim JK; Edwards CA; Xu Z; Taichman R; Wang CY
Nat Cell Biol; 2005 Sep; 7(9):909-15. PubMed ID: 16113678
[TBL] [Abstract][Full Text] [Related]
18. A novel group of genes regulates susceptibility to antineoplastic drugs in highly tumorigenic breast cancer cells.
Mallory JC; Crudden G; Oliva A; Saunders C; Stromberg A; Craven RJ
Mol Pharmacol; 2005 Dec; 68(6):1747-56. PubMed ID: 16150928
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling.
Clarke R; Liu MC; Bouker KB; Gu Z; Lee RY; Zhu Y; Skaar TC; Gomez B; O'Brien K; Wang Y; Hilakivi-Clarke LA
Oncogene; 2003 Oct; 22(47):7316-39. PubMed ID: 14576841
[TBL] [Abstract][Full Text] [Related]
20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
